Russell A. Gazzara - Publications

Affiliations: 
1989-1997 Psychology State University of New York at Binghamton, Vestal, NY, United States 
Area:
Developmental Psychobiology
Website:
https://gangemifuneralhome.net/book-of-memories/1861689/GazzaraPhD-Russell/obituary.php

17/36 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
1998 Holson RR, Gazzara RA, Gough B. Declines in stimulated striatal dopamine release over the first 32 h following microdialysis probe insertion: generalization across releasing mechanisms. Brain Research. 808: 182-9. PMID 9767162 DOI: 10.1016/S0006-8993(98)00816-6  0.588
1997 Gazzara RA, Andersen SL. The effects of bupropion in vivo in the neostriatum of 5-day-old and adult rats Developmental Brain Research. 100: 139-142. PMID 9174258 DOI: 10.1016/S0165-3806(97)00006-0  0.787
1997 Gazzara R. Amphetamine-evoked dopamine release in the neostriatum of the developing rat: an in vivo microdialysis study Neurotoxicology and Teratology. 19: 255. DOI: 10.1016/S0892-0362(97)82437-3  0.7
1996 Andersen SL, Gazzara RA. Effects of (-)-sulpiride on dopamine release in striatum of developing rats: Degree of depolarization influences responsiveness Journal of Neurochemistry. 67: 1931-1937. PMID 8863497 DOI: 10.1046/J.1471-4159.1996.67051931.X  0.782
1995 Gazzara R. In vivo microdialysis as a method to assess dopamine function in the neostriatum of the developing rat Neurotoxicology and Teratology. 17: 388. DOI: 10.1016/0892-0362(95)93399-K  0.542
1994 Gazzara RA, Andersen SL. The ontogeny of apomorphine-induced alterations of neostriatal dopamine release: Effects on potassium-evoked release Neurochemical Research. 19: 339-345. PMID 8177374 DOI: 10.1007/Bf00971583  0.783
1994 Gazzara RA, Andersen SL. Calcium dependency and tetrodotoxin sensitivity of neostriatal dopamine release in 5-day-old and adult rats as measured by in vivo microdialysis Journal of Neurochemistry. 62: 1741-1749. PMID 8158124 DOI: 10.1046/J.1471-4159.1994.62051741.X  0.776
1994 Andersen SL, Gazzara RA. The development of D2 autoreceptor-mediated modulation of K+-evoked dopamine release in the neostriatum Developmental Brain Research. 78: 123-130. PMID 7911744 DOI: 10.1016/0165-3806(94)90016-7  0.769
1993 Andersen SL, Gazzara RA. The ontogeny of apomorphine-induced alterations of neostriatal dopamine release: Effects on spontaneous release Journal of Neurochemistry. 61: 2247-2255. PMID 8245975 DOI: 10.1111/J.1471-4159.1993.Tb07466.X  0.77
1992 Andersen SL, Gazzara RA, Robinson SR, Smotherman WP. Effect of milk on dopamine release in the newborn rat: an in vivo microdialysis study. Brain Research. Developmental Brain Research. 68: 286-8. PMID 1394974 DOI: 10.1016/0165-3806(92)90073-6  0.771
1990 Chapman CD, Gazzara RA, Howard SG. Effects of phencyclidine on extracellular levels of dopamine, dihydroxyphenylacetic acid and homovanillic acid in conscious and anesthetized rats. Neuropharmacology. 29: 319-25. PMID 2342635  0.767
1989 Gazzara RA, Takeda H, Cho AK, Howard SG. Inhibition of dopamine release by methylenedioxymethamphetamine is mediated by serotonin. European Journal of Pharmacology. 168: 209-17. PMID 2575036 DOI: 10.1016/0014-2999(89)90567-0  0.772
1986 Gazzara RA, Fisher RS, Howard SG. The ontogeny of amphetamine-induced dopamine release in the caudate-putamen of the rat. Brain Research. 393: 213-20. PMID 3742239 DOI: 10.1016/0165-3806(86)90023-4  0.784
1986 Cushing SD, Howard-Butcher S, Gazzara RA, Lettes AA, Mulliez E, Cho AK. 3H-xylamine binds to presynaptic rat striatal membranes. Life Sciences. 38: 1715-21. PMID 3702601 DOI: 10.1016/0024-3205(86)90121-9  0.584
1986 Takeda H, Gazzara RA, Howard SG. Phenylcyclohexylamine: effect of a metabolite of phencyclidine on the efflux of dopamine in the rat. Neuropharmacology. 25: 1341-5. PMID 3561712  0.78
1986 GAZZARA RA, HOWARD-BUTCHER S. A Developmental Study of Amphetamine-Induced Dopamine Release in Rats Using in Vivo Voltammetry Annals of the New York Academy of Sciences. 473: 527-529. DOI: 10.1111/J.1749-6632.1986.TB23650.X  0.696
1981 Gazzara RA, Altman J. Early postnatal x-irradiation of the hippocampus and discrimination learning in adult rats. Journal of Comparative and Physiological Psychology. 95: 484-95. PMID 7251955  0.443
Low-probability matches (unlikely to be authored by this person)
1974 Brunner RL, Haggbloom SJ, Gazzara RA. Effects of hippocampal x-irradiation-produced granule cell agenesis on instrumental runway performance in rats. Physiology & Behavior. 13: 485-94. PMID 4475430 DOI: 10.1016/0031-9384(74)90278-9  0.288
1998 Ferguson SA, Holson RR, Gazzara RA, Siitonen PH. Minimal behavioral effects from moderate postnatal lead treatment in rats Neurotoxicology and Teratology. 20: 637-643. PMID 9831125 DOI: 10.1016/S0892-0362(98)00023-3  0.242
1997 Holson RR, Gazzara RA, Ferguson SA, Ali SF, Laborde JB, Adams J. Gestational retinoic acid exposure: A sensitive period for effects on neonatal mortality and cerebellar development Neurotoxicology and Teratology. 19: 335-346. PMID 9380000 DOI: 10.1016/S0892-0362(97)00039-1  0.199
1997 Holson RR, Gazzara RA, Ferguson SA, Adams J. Behavioral effects of Low-Dose gestational day 11-13 retinoic acid exposure Neurotoxicology and Teratology. 19: 355-362. PMID 9380002 DOI: 10.1016/S0892-0362(97)00041-X  0.171
1997 Holson R, Ferguson S, Houston R, Gazzara R, Adams J. Gestational stage-specific effects of retinoic acid (RA) exposure on rat brain and behavior: A progress report Neurotoxicology and Teratology. 19: 258-259. DOI: 10.1016/S0892-0362(97)82447-6  0.163
2006 Ballantyne C, Abate N, Yuan Z, Gazzara R, Tershakovec A. Th-P16:282 A ‘step-up’ dose comparison of the ezetimibe/simvastatin single tablet versus atorvastatin in patients with hypercholesterolemia Atherosclerosis Supplements. 7: 555. DOI: 10.1016/S1567-5688(06)82240-3  0.151
1997 Holson RR, Gazzara RA, Ferguson SA, Adams J. A behavioral and neuroanatomical investigation of the lethality caused by gestational day 11-13 retinoic acid exposure Neurotoxicology and Teratology. 19: 347-353. PMID 9380001 DOI: 10.1016/S0892-0362(97)00040-8  0.151
1996 Holson R, Ferguson S, Gazzara R, Adams J. Prenatal retinoic acid exposure: II. Neuroanatomical effects of retinoic acid on gestational days (GD) 11–13 Neurotoxicology and Teratology. 18: 337. DOI: 10.1016/S0892-0362(96)90099-9  0.14
2006 Davidson M, Catapano A, Ballantyne C, Brady W, Gazzara R, Tershakovec A. Th-P16:280 Attainment of optimal NCEP ATP III treatment goals in high-risk patients: Dose comparison of ezetimibe/simvastatin and rosuvastatin Atherosclerosis Supplements. 7: 555. DOI: 10.1016/S1567-5688(06)82238-5  0.103
2006 Catapano AL, Davidson MH, Ballantyne CM, Brady WE, Gazzara RA, Tomassini JE, Tershakovec AM. Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients. Current Medical Research and Opinion. 22: 2041-53. PMID 17022864 DOI: 10.1185/030079906X132721  0.101
1983 Fisher RS, Levine MS, Gazzara RA, Hull CD, Buchwald NA. Postnatal development of caudate input neurons in the cat. The Journal of Comparative Neurology. 219: 51-69. PMID 6619332 DOI: 10.1002/cne.902190106  0.101
2004 Compan V, Zhou M, Grailhe R, Gazzara RA, Martin R, Gingrich J, Dumuis A, Brunner D, Bockaert J, Hen R. Attenuated response to stress and novelty and hypersensitivity to seizures in 5-HT4 receptor knock-out mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 412-9. PMID 14724239 DOI: 10.1523/Jneurosci.2806-03.2004  0.091
1996 Ferguson S, Holson R, Gazzara R, Adams J. Prenatal retinoic acid exposure: III. Behavioral effects of retinoic acid on GD 11–13 Neurotoxicology and Teratology. 18: 337. DOI: 10.1016/S0892-0362(96)90101-4  0.083
2006 Calapano A, Ballantyne C, Abate N, Davidson M, Brady W, Gazzara R, Tershakovec A. Th-P16:281 Evaluation of the ezetimibe/simvastatin tablet compared with atorvastatin or rosuvastatin on C-reactive protein in patients with hypercholesterolemia Atherosclerosis Supplements. 7: 555. DOI: 10.1016/S1567-5688(06)82239-7  0.079
1996 Gazzara R, Holson R, Ferguson S, Ali S, Adams J. Prenatal retinoic acid exposure: I. Effects on neonatal lethality and regional brain weights Neurotoxicology and Teratology. 18: 337. DOI: 10.1016/S0892-0362(96)90097-5  0.069
2006 Denke M, Pearson T, McBride P, Gazzara RA, Brady WE, Tershakovec AM. Ezetimibe added to ongoing statin therapy improves LDL-C goal attainment and lipid profile in patients with diabetes or metabolic syndrome. Diabetes & Vascular Disease Research. 3: 93-102. PMID 17058629 DOI: 10.3132/dvdr.2006.020  0.061
2006 Davidson M, Catapano A, Ballantyne C, Brady W, Gazzara R, Tershakovec A. Th-P16:283 Lipid-altering efficacy and safety of ezetimibe/simvastatin versus rosuvastatin in patients with primary hypercholesterolemia Atherosclerosis Supplements. 7: 555. DOI: 10.1016/S1567-5688(06)82241-5  0.06
1986 Gazzara RA, Fisher RS, Levine MS, Hull CD, Buchwald NA. Physiological and morphological analyses of ventral anterior and ventral lateral thalamic neurons in the cat. Brain Research. 397: 225-37. PMID 3801868 DOI: 10.1016/0006-8993(86)90623-2  0.051
2006 Pearson TA, Denke MA, McBride PE, Battisti WP, Gazzara RA, Brady WE, Palmisano J. Effectiveness of ezetimibe added to ongoing statin therapy in modifying lipid profiles and low-density lipoprotein cholesterol goal attainment in patients of different races and ethnicities: a substudy of the Ezetimibe add-on to statin for effectiveness trial. Mayo Clinic Proceedings. 81: 1177-85. PMID 16970214 DOI: 10.4065/81.9.1177  0.044
Hide low-probability matches.